Medications for Influenza B Virus
12 results
Oseltamivir (oseltamivir)
(OSELTAMIVIR)Alembic Pharmaceuticals Inc.
Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. It is also used for prophylaxis in individuals 1 year and older. Vaccination is recommended annually and resistance may impact effectiveness.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)Neolpharma Inc
Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. It is also used for prophylaxis of influenza in individuals 1 year and older.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)Asclemed USA, Inc.
Usage: Oseltamivir phosphate for oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older within 48 hours of symptoms. It is also indicated for prophylaxis of influenza A and B in patients 1 year and older.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)NuCare Pharmaceuticals,Inc.
Usage: Oseltamivir Phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in patients aged 1 year and older. It is not a substitute for annual vaccinations.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir phosphate)Novadoz Pharmaceuticals LLC
Usage: Oseltamivir phosphate capsules are indicated for the treatment of influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. It is not a substitute for annual influenza vaccination.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)Lupin Pharmaceuticals Inc
Usage: Oseltamivir phosphate for oral suspension is indicated for treating acute influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in individuals 1 year and older. It is not a substitute for annual vaccination and has specific use limitations.
Oseltamivir phosphate (oseltamivir phosphate)
(oseltamivir phosphate)Novadoz Pharmaceuticals LLC
Usage: Oseltamivir phosphate for oral suspension is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older with symptoms for no more than 48 hours, and for prophylaxis in patients aged 1 year and older. It is not a substitute for vaccination.
Oseltamivir phosphate (oseltamivir phosphate)
(oseltamivir phosphate)Redpharm Drug
Usage: Oseltamivir phosphate capsules are indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, and for prophylaxis in those aged 1 year and older. It is not a substitute for annual flu vaccination and has limitations regarding drug resistance and specific populations.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir phosphate)Redpharm Drug
Usage: Oseltamivir phosphate capsules are indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. They are not a substitute for vaccination and have specific limitations for use.
Oseltamivir phosphate (oseltamivir phosphate)
(OSELTAMIVIR PHOSPHATE)Aurobindo Pharma Limited
Usage: Oseltamivir phosphate oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptoms onset, and for prophylaxis in patients 1 year and older. It is not a substitute for vaccination and may have limitations due to resistance.